Yap LB - Search Results

1

A Comparison of Dabigatran With Warfarin for Stroke Prevention in Atrial Fibrillation in an Asian Population.

Yap LB, Eng DT, Sivalingam L, Rusani BI, Umadevan D, Muhammad Z, Koh KW, Aisha B, Hashim MI, Rebo R, Hussin A, Kaur S, Shanmugam R, Omar R. Yap LB, et al. Clin Appl Thromb Hemost. 2016 Nov;22(8):792-797. doi: 10.1177/1076029615584664. Epub 2015 May 11. Clin Appl Thromb Hemost. 2016. PMID: 25962393 Free article.

2

Hypertrophic obstructive cardiomyopathy successfully treated with DDD pacing.

Yap LB, Omar R. Yap LB, et al. Int J Cardiol. 2013 Jul 15;167(1):e14-6. doi: 10.1016/j.ijcard.2013.01.265. Epub 2013 Feb 26. Int J Cardiol. 2013. PMID: 23484735 No abstract available.

3

A single centre experience of the efficacy and safety of dabigatran etexilate used for stroke prevention in atrial fibrillation.

Yap LB, Rusani BI, Umadevan D, Muhammad Z, Hussin A, Kaur S, Omar R. Yap LB, et al. J Thromb Thrombolysis. 2014 Jul;38(1):39-44. doi: 10.1007/s11239-013-1020-y. J Thromb Thrombolysis. 2014. PMID: 24197653

4

The clinical benefit of cardiac resynchronization therapy for narrow QRS compared to broad QRS complex patients.

Yap LB, Qadir F, Nguyen ST, Ma SK, Koh KW, Muhammad Z, Arshad AH, Ali Z, Daud A, Tay GS, Sahat NA, Said AA, Tamin SS, Hussin A, Kaur S, Omar R. Yap LB, et al. Int J Cardiol. 2015 Mar 15;183:178-9. doi: 10.1016/j.ijcard.2015.01.042. Epub 2015 Jan 26. Int J Cardiol. 2015. PMID: 25666128 No abstract available.

5

A comparison of long-term outcomes between narrow and broad QRS complex patients treated with cardiac resynchronization therapy.

Yap LB, Nguyen ST, Qadir F, Ma SK, Muhammad Z, Koh KW, Ali Z, Tay GS, Daud A, Said A, Sahat N, Rebo R, Tamin SS, Hussin A, Kaur S, Omar R. Yap LB, et al. Acta Cardiol. 2016 Jun;71(3):323-30. doi: 10.2143/AC.71.3.3152093. Acta Cardiol. 2016. PMID: 27594128 No abstract available.

6

Evaluation of the predictive performance of bleeding risk scores in patients with non-valvular atrial fibrillation on oral anticoagulants.

Beshir SA, Aziz Z, Yap LB, Chee KH, Lo YL. Beshir SA, et al. Among authors: yap lb. J Clin Pharm Ther. 2018 Apr;43(2):209-219. doi: 10.1111/jcpt.12634. Epub 2017 Oct 13. J Clin Pharm Ther. 2018. PMID: 29030869

7

Assessment of Predicted Rate and Associated Factors of Dabigatran-induced Bleeding Events in Malaysian Patients with Non-Valvular Atrial Fibrillation.

Beshir SA, Yap LB, Sim S, Chee KH, Lo YL. Beshir SA, et al. Among authors: yap lb. J Pharm Pharm Sci. 2017;20(1):365-377. doi: 10.18433/J3TP9Q. J Pharm Pharm Sci. 2017. PMID: 29145930 Free article.

8

A comparison of dabigatran and warfarin for stroke prevention in elderly Asian population with nonvalvular atrial fibrillation: An audit of current practice in Malaysia.

Yap SH, Ng YP, Roslan A, Kolanthaivelu J, Koh KW, P'ng HS, Boo YL, Hoo FK, Yap LB. Yap SH, et al. Among authors: yap lb. Med J Malaysia. 2017 Dec;72(6):360-364. Med J Malaysia. 2017. PMID: 29308774 Free article.

9

Treatment of severe coronary artery calcification with intravascular lithotripsy: Initial experience of a prospective single centre registry.

Yap LB, Choy CN, Navin S, Koh KW, Jeyamalar R, Balachandran K. Yap LB, et al. Med J Malaysia. 2022 Jul;77(4):500-505. Med J Malaysia. 2022. PMID: 35902942 Free article.

10

Intravascular imaging-guided treatment of severe coronary artery calcification with orbital atherectomy: A prospective single-centre registry.

Yap LB, Choy CN, Navin S, Koh KW, Jeyamalar R, Balachandran K. Yap LB, et al. Med J Malaysia. 2023 Jan;78(1):7-13. Med J Malaysia. 2023. PMID: 36715184 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters